Journal Article Retraction Notice Ahead of print
PubMed: 42881241 DOI: 10.1038/s41416-026-03646-0
Retraction Note: Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma.
Br J Cancer
Authors: M Gkotzamanidou, P P Sfikakis, S A Kyrtopoulos, C Bamia, M A Dimopoulos, V L Souliotis
Affiliations
- Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, 11528, Greece.
- First Department of Propedeutic Medicine, University of Athens School of Medicine, Athens, 11527, Greece.
- Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, Athens, 11635, Greece.
- Department of Hygiene, Epidemiology and Medical Statistics, University of Athens School of Medicine, Athens, 11527, Greece.
- Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, 11528, Greece.
- Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, Athens, 11635, Greece.
MeSH
Dna Repair, Neoplasms, Chromatin, Drug Therapy, Multiple Myeloma, Chemotherapy